Calcium Dobesilate Capsules

This product regulates the physiological function of the microvascular wall, reduces plasma viscosity, reduces platelet aggregation and other mechanisms, thereby regulating microcirculation function and playing a role in treating retinal microcirculation lesions caused by diabetes.

The main component of this product is calcium dobesilate monohydrate. Chemical name: 2,5-dihydroxybenzenesulfonate calcium monohydrate Molecular weight: C12H10CaO10S2. H2O

This product is a capsule, and the contents are white or off-white powder or granules.

Swallow with meals. During the initial treatment phase, take one tablet three times a day. After 4 to 6 weeks, adjust to taking one tablet twice a day.

Occasionally, symptoms such as stomach discomfort, nausea, heartburn, and lack of appetite may occur; in this case, the dosage should be reduced as appropriate and administration should be suspended if necessary.

Use with caution if you are allergic to this product.

Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Not yet clear.

Drug interactions may occur if used with other drugs. Please consult your doctor or pharmacist for details.

Sealed. Store in a cool, dark, dry place.

0.5 g

24 months

Shuanghe Tian'an Pharmaceutical (Guizhou) Co., Ltd.

• Founded in:

  2002-12-13

• Address:

  No. 25 Gaoxin Road, Wudang District, Guiyang City, Guizhou Province

• Tax NO.:

  91520000750185534P

• Registered Funds:

  36.7 million yuan

• Email:

  Log in to view